• Lynparza Improves Response Rate in Relapsed BRCA-mutated Advanced OC Patients
  • Triple Combination Works Well in Recurrent Ovarian Cancer with Smaller Tumors, Study Shows
  • Talc May Be Tied to Ovarian Cancer and Serious Lung Problems, Health Canada Warns
  • New Steps Through OC Pilot Program Offers Support to Ovarian Cancer Patients and Caregivers
  • 4 New Research Grants to Promote Study of Tumor Treating Fields as Cancer Therapy
  • BRACAnalysis CDx Approved in US as Companion Diagnostic Test for First-line Lynparza Treatment
  • Lynparza Approved in U.S. as First-line Maintenance Therapy for BRCA-positive Advanced Ovarian Cancer
  • Top 10 Ovarian Cancer Stories of 2018
  • Newk’s Cares Campaign to Battle Ovarian Cancer Enters Fifth Year
  • Bacterial Toxin-based Test Could Help Detect Ovarian Cancer Early
  • Stanford Pursues New Research to Understand Spread and Resistance of Aggressive Ovarian Cancer
  • Bavencio Fails to Meet Primary Objectives in Certain Ovarian Cancer Patients in Phase 3 Trial